18889881171
Kalkine 0
countryflagUS
Login|.

AAPL 222.9 0.3466% MSFT 381.32 1.5797% NVDA 109.1 0.6643% GOOGL 157.3899 1.7783% GOOG 159.281 1.9529% AMZN 193.1756 1.5324% META 588.5625 2.1172% AVGO 167.25 -0.1075% LLY 814.69 -1.3585% TSLA 274.8 6.0349% TSM 168.36 1.4217% V 345.88 -1.3069% JPM 244.28 -0.4158% UNH 526.1799 0.4639% NVO 68.6257 -1.1727% WMT 89.025 1.4068% LVMUY 123.77 -0.2659% XOM 118.71 -0.185% LVMHF 625.0 0.5389% MA 548.3 0.0328%
AAPL 222.9 0.3466% MSFT 381.32 1.5797% NVDA 109.1 0.6643% GOOGL 157.3899 1.7783% GOOG 159.281 1.9529% AMZN 193.1756 1.5324% META 588.5625 2.1172% AVGO 167.25 -0.1075% LLY 814.69 -1.3585% TSLA 274.8 6.0349% TSM 168.36 1.4217% V 345.88 -1.3069% JPM 244.28 -0.4158% UNH 526.1799 0.4639% NVO 68.6257 -1.1727% WMT 89.025 1.4068% LVMUY 123.77 -0.2659% XOM 118.71 -0.185% LVMHF 625.0 0.5389% MA 548.3 0.0328%

Shop Apotheke Europe N.V

Healthcare US SHPPF

139.63USD
-(-%)

Last update at 2025-03-31T20:00:00Z

Day Range

139.16139.16
LowHigh

52 Week Range

47.6547.65
LowHigh

Fundamentals

  • Previous Close 139.63
  • Market Cap4467.22M
  • Volume100
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA15.13M
  • Revenue TTM1595.27M
  • Revenue Per Share TTM66.97
  • Gross Profit TTM 331.79M
  • Diluted EPS TTM-4.63

Analyst Recommendations

Financials

Income Statement

2018-12-312019-12-312020-12-312021-12-312022-12-310M100M200M300M400M500M600M700M800M900M1000M1100M1200M
Total Revenue
Net Income

Balancesheet

2018-12-312019-12-312020-12-312021-12-312022-12-310M100M200M300M400M500M600M700M
Total Assets
Total Liabilities

Change in Cash

2018-12-312019-12-312020-12-312021-12-312022-12-31-150M-100M-50M0M50M100M150M

Total Operating Cash

2018-12-312019-12-312020-12-312021-12-312022-12-31-35M-30M-25M-20M-15M-10M-5M0M5M10M15M20M

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -84.11900M -77.88400M -15.93200M -42.18000M -34.59100M
Minority interest - - - - -
Net income -77.64600M -74.18500M -16.77100M -36.27000M -33.60900M
Selling general administrative 244.24M 196.88M 145.24M 108.71M 81.42M
Selling and marketing expenses - - - - -
Gross profit 331.79M 266.53M 219.53M 137.68M 99.32M
Reconciled depreciation 39.51M 26.96M 16.06M 14.86M 13.17M
Ebit -47.23100M -32.25000M 5.56M -28.43500M -27.67100M
Ebitda -36.10400M -42.35400M 10.55M -19.83200M -15.23400M
Depreciation and amortization - - - - -
Non operating income net other - - - - -
Operating income -69.32100M -43.40800M -0.93100M -34.18200M -28.92500M
Other operating expenses 0.15M 0.16M 0.07M 0.15M 0.20M
Interest expense 8.50M 8.57M 10.41M 7.48M 6.18M
Tax provision -6.47300M -3.69900M 0.84M -5.91000M -0.98200M
Interest income 0.27M 0.03M 0.09M 0.11M 0.32M
Net interest income -14.02900M -13.09100M -14.47900M -10.03100M -5.86100M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense -6.47300M -3.69900M 0.84M -5.91000M -0.98200M
Total revenue 1204.35M 1060.32M 968.06M 701.01M 539.71M
Total operating expenses 1273.67M 1103.73M 968.99M 735.19M 568.64M
Cost of revenue 872.57M 793.79M 748.53M 563.33M 440.39M
Total other income expense net - - - - -
Discontinued operations - - - - -
Net income from continuing ops -77.64600M -74.18500M -16.77100M -36.27000M -33.60900M
Net income applicable to common shares -77.64600M -74.18500M -16.77100M -36.27000M -33.60900M
Preferred stock and other adjustments - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 729.47M 783.08M 536.91M 427.98M 350.91M
Intangible assets 119.43M 104.35M 75.54M 70.73M 63.30M
Earning assets - - - - -
Other current assets 12.35M 12.45M 9.90M 8.50M 6.14M
Total liab 374.84M 367.66M 111.77M 195.22M 136.93M
Total stockholder equity 354.63M 415.41M 425.14M 232.76M 213.98M
Deferred long term liab - - - - 0.00500M
Other current liab 4.18M 3.18M 2.21M 0.98M 2.50M
Common stock 0.36M 0.36M 0.35M 0.27M 0.24M
Capital stock 0.36M 0.36M 0.35M 0.27M 292.05M
Retained earnings -285.42800M -207.78200M -133.72100M -120.23000M -83.96000M
Other liab 28.19M 22.15M 4.35M 3.90M 10.84M
Good will 169.57M 153.13M 129.12M 129.12M 129.29M
Other assets 9.85M 13.11M 1.85M 0.12M 0.97M
Cash 66.44M 247.04M 90.11M 62.65M 24.34M
Cash and equivalents - - - - -
Total current liabilities 119.31M 124.08M 74.61M 59.80M 52.66M
Current deferred revenue - - - - -
Net debt 155.28M - - 80.14M 57.20M
Short term debt - - - - -
Short long term debt 1.67M 1.66M 0.04M 15.43M 13.89M
Short long term debt total - - - - -
Other stockholder equity 69.00M 56.30M 6.84M 11.80M 5.89M
Property plant equipment 85.44M 78.26M 74.55M 13.18M 11.92M
Total current assets 343.92M 432.76M 254.09M 210.81M 135.69M
Long term investments - - - - -
Net tangible assets 65.62M 157.94M 220.48M 32.91M 14.08M
Short term investments 117.56M 36.41M 37.77M 50.58M 34.42M
Net receivables 40.95M 36.16M 29.98M 26.71M 22.05M
Long term debt 220.06M 203.97M 4.08M 127.36M 67.65M
Inventory 99.71M 96.62M 81.24M 56.69M 43.35M
Accounts payable 68.94M 78.12M 51.32M 31.35M 26.08M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - 0.00200M - 0.00100M -0.00100M
Deferred long term asset charges - - - - -
Non current assets total 385.56M 350.31M 282.82M 217.16M 214.20M
Capital lease obligations 33.47M 30.80M 34.12M 6.41M 7.17M
Long term debt total - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -80.49300M 2.41M 13.08M -18.65800M -22.32300M
Change to liabilities -12.24500M 26.51M 21.08M 5.56M 5.42M
Total cashflows from investing activities -138.00900M -84.29700M -40.16400M -33.40000M -38.55700M
Net borrowings -7.08400M 223.75M -12.52700M 56.50M 71.28M
Total cash from financing activities -13.51500M 229.59M 50.19M 102.44M 66.50M
Change to operating activities 0.62M 23.97M 5.94M 5.94M 5.94M
Net income -77.64600M -74.18500M -16.77100M -36.27000M -33.60900M
Change in cash -180.63600M 156.93M 27.83M 38.31M 13.42M
Begin period cash flow 247.41M 90.48M 62.65M 24.34M 10.92M
End period cash flow 66.78M 247.41M 90.48M 62.65M 14.53M
Total cash from operating activities -29.11200M 11.63M 17.80M -30.72800M -14.52500M
Issuance of capital stock 0.64M 12.22M 75.74M 49.15M -
Depreciation 18.19M 15.62M 9.77M 10.20M 9.67M
Other cashflows from investing activities 2.02M -12.37000M 0.09M 0.09M 0.09M
Dividends paid - - - - -
Change to inventory -3.08400M -15.37500M -24.55200M -13.33900M 0.13M
Change to account receivables -2.27700M -6.58100M -3.69700M -7.31400M -5.17400M
Sale purchase of stock - - - - -
Other cashflows from financing activities -7.06800M -6.37800M -13.01800M -3.20400M -4.77800M
Change to netincome 26.00M 30.34M 19.75M 6.02M 5.54M
Capital expenditures 13.56M 13.82M 38.23M 4.00M 2.80M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -16.98100M 28.52M -1.23700M -14.72700M -9.42600M
Stock based compensation 16.23M 20.54M 4.41M 2.97M -
Other non cash items - - - - -
Free cash flow -82.63600M -31.52400M -35.53300M -45.10800M -35.39600M

Peer Comparison

Sector: Healthcare Industry: Pharmaceutical Retailers

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
SHPPF
Shop Apotheke Europe N.V		 - -% 139.63 - - 2.80 2.28 1.70 78.78
WBA
Walgreens Boots Alliance Inc		 -0.035 0.31% 11.13 - 5.40 0.11 1.14 0.33 -4.3066
RADLY
Raia Drogasil SA ADR		 - -% 3.67 47.15 32.68 0.34 9.83 0.35 3.29
ALBHF
Alibaba Health Information Technology Limited		 - -% 0.61 50.80 29.59 0.30 3.62 1.58 34.83
ALBBY
Alibaba Health Information Technology Limited		 - -% 11.93 48.10 30.30 0.29 3.70 1.58 34.83

Reports Covered

Stock Research & News

View All

Profile

Redcare Pharmacy NV owns and operates online pharmacies in the Netherlands, Germany, Italy, Belgium, Switzerland, Austria, and France. It provides prescription medications, over-the-counter medications, and pharmacy-related beauty and personal care products, as well as food supplements. The company was formerly known as Shop Apotheke Europe N.V. and changed its name to Redcare Pharmacy NV in June 2023. Redcare Pharmacy NV was founded in 2001 and is headquartered in Sevenum, the Netherlands.

Shop Apotheke Europe N.V

Erik de Rodeweg 11?13, Sevenum, Netherlands, 5975 WD

Key Executives

Name Title Year Born
Mr. Stefan Feltens Chairman of the Managing Board & CEO 1965
Mr. Stephan Weber Co-Founder, Chief Commercial Officer, Deputy CEO & Member of the Managing Board 1979
Mr. Marc Fischer Co-Founder, Chief Information Officer & Member of the Managing Board 1975
Mr. Jasper F. P. Eenhorst CFO & Member of Management Board 1973
Ms. Theresa Holler COO & Member of the Managing Board 1973
Mr. Patrick Schneider Chief Sales Officer NA
Ms. Beate Krosch Director of HR NA
Mr. Nana Lohmanns Chief E-Health Officer NA
Mr. Dirk Bruse Chief Brand Officer NA
Mr. Jens Wolfgarten Chief Product Officer - Retail NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.